<img alt="" height="1" width="1" />Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009Reuters... was recognized in the second quarter of 2008 from the initial stocking of Amitiza (8 mcg) for irritable bowel syndrome with constipation (IBS-C). ...<nobr>and more »</nobr> |